Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transurethral Periprostatectomy Treatment of Cancerous Prostate Tissue (Peri III Study)

NCT07561502 is registered in ClinicalTrials.gov with Francis Medical Inc. as lead sponsor.

NCT NCT07561502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07561502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transurethral Periprostatectomy Treatment of Cancerous Prostate Tissue (Peri III Study)
Lead sponsor
Francis Medical Inc.
Phase
Not applicable
Overall status
Completed
Start date
November 14, 2022
Completion date
August 11, 2023
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer